Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
76.63
-48.18
-62.87%
Share Warrants & Outstandings
Total Reserve
107.51
-17.15
124.66
726.88%
Shareholder's Funds
138.48
59.48
79.00
132.82%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
2.70
-0.71
-26.30%
Secured Loans
1.99
2.70
-0.71
-26.30%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.92
-0.91
1.83
201.10%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.47
-0.47
-100.00%
Total Non-Current Liabilities
2.91
2.26
0.65
28.76%
Current Liabilities
Trade Payables
102.54
7.53
95.01
1,261.75%
Other Current Liabilities
11.07
7.21
3.86
53.54%
Short Term Borrowings
32.87
8.31
24.56
295.55%
Short Term Provisions
2.73
0.09
2.64
2,933.33%
Total Current Liabilities
149.21
23.14
126.07
544.81%
Total Liabilities
290.59
84.88
205.71
242.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
14.96
24.14
161.36%
Less: Accumulated Depreciation
22.88
3.00
19.88
662.67%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
11.95
4.27
35.73%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
25.52
-23.40
-91.69%
Long Term Loans & Advances
6.64
5.70
0.94
16.49%
Other Non Current Assets
0.01
0.00
0.01
0.00%
Total Non-Current Assets
24.98
43.17
-18.19
-42.14%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
0.07
45.41
64,871.43%
Sundry Debtors
133.46
0.42
133.04
31,676.19%
Cash and Bank
1.47
3.68
-2.21
-60.05%
Other Current Assets
0.78
18.94
-18.16
-95.88%
Short Term Loans and Advances
84.41
18.59
65.82
354.06%
Total Current Assets
265.61
41.71
223.90
536.80%
Net Current Assets (Including Current Investments)
116.40
18.56
97.84
527.16%
Total Current Assets Excluding Current Investments
265.61
41.71
223.90
536.80%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
84.88
205.71
242.35%
Contingent Liabilities
0.00
61.35
-61.35
-100.00%
Total Debt
34.86
11.01
23.85
216.62%
Book Value per share (adjusted)
46.90
7.76
39.14
504.38%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






